How high-risk Botox habits have become normalised for twentysomethings like me

As the beauty industry warns that Botox and fillers should be considered high-risk procedures, Lydia Spencer-Elliott unpacks ...
Le Lézard

Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate ...